Trane Technologies CEO sells 48,091 shares

Q: How many TT shares did David S. Regnery sell, and at what price?

David S. Regnery, Trane Technologies' Chair and CEO, sold 48,091 ordinary shares at $480 per share on October 6, 2026. The sale was executed under a Rule 10b5-1 plan adopted May 4, 2026.

Q: How many TT shares did David S. Regnery acquire through options?

David S. Regnery exercised options covering 48,091 ordinary shares at an exercise price of $78.97 per share on October 6, 2026. The options vested in three pro rata annual installments beginning February 5, 2020.

The exercised options had vested in three pro rata annual installments beginning February 5, 2020.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Trane Technologies plc (TT) Chair and CEO David S. Regnery exercised options covering 48,091 ordinary shares on October 6, 2026, at an exercise price of $78.97 per share, then sold 48,091 shares at $480 per share under a Rule 10b5-1 plan adopted May 4, 2026. His reported stock-option position after exercise was zero. A separate indirect holding lists 24,500 ordinary shares in a revocable trust established by his spouse, who is the sole trustee and beneficiary.

Insider Trade Summary 10b5-1

Exercise and Sale: 48,091 shares ($19.29M approx. pre-tax spread)

Exercise and Sale 4 txns

Insider Regnery David S

Role Chair and CEO

Sold 48,091 shs ($23.08M)

Approx. gross sale proceeds $23.08M

Approx. exercise cost $3.80M

Approx. pre-tax spread $19.29M

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) ^F3	48,091	$0.00	$0.00
Exercise	Ordinary Shares	48,091	$78.97	$3.80M
Sale	Ordinary Shares ^F1	48,091	$480.00	$23.08M
holding	Ordinary Shares (Trust) ^F2	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Ordinary Shares — 96,951.43 shares (Direct); Ordinary Shares (Trust) — 24,500 shares (Indirect, By Revocable Trust)

Footnotes (3)

F1. Transaction executed pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 4, 2026.
F2. Shares held by a revocable trust established by the reporting person's spouse, of which trust the reporting person's spouse is the sole trustee and sole beneficiary.
F3. The stock option vested in three (3) pro rata annual installments beginning on February 5, 2020.

Key Figures

Shares acquired through option exercise: 48,091 shares Exercise price: $78.97 per share Sale price: $480 per share +2 more

5 metrics

Shares acquired through option exercise 48,091 shares Ordinary shares on October 6, 2026

Exercise price $78.97 per share Options exercised on October 6, 2026

Sale price $480 per share 48,091 ordinary shares sold on October 6, 2026

Stock-option shares following transaction 0 shares Direct position after the October 6, 2026 exercise

Ordinary shares held indirectly in revocable trust 24,500 shares Trust established by the reporting person's spouse

Key Terms

Rule 10b5-1 Plan, Stock Option (Right to Buy), pro rata annual installments

3 terms

Rule 10b5-1 Plan regulatory

"pursuant to a Rule 10b5-1 Plan"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

pro rata annual installments financial

"vested in three (3) pro rata annual installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TT shares did David S. Regnery sell, and at what price?

David S. Regnery, Trane Technologies' Chair and CEO, sold 48,091 ordinary shares at $480 per share on October 6, 2026. The sale was executed under a Rule 10b5-1 plan adopted May 4, 2026.

How many TT shares did David S. Regnery acquire through options?

David S. Regnery exercised options covering 48,091 ordinary shares at an exercise price of $78.97 per share on October 6, 2026. The options vested in three pro rata annual installments beginning February 5, 2020.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/08/2026 - 04:12 PM Accepted by SEC EDGAR 10/08/2026 - 04:11 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Regnery David S

(Last)

(First)

(Middle)

C/O TRANE TECHNOLOGIES COMPANY LLC

800-E BEATY STREET

(Street)

DAVIDSON

NORTH CAROLINA

28036

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Trane Technologies plc [ TT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chair and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	10/06/2026		M		48,091	A	$78.97	145,042.43	D
Ordinary Shares	10/06/2026		S		48,091⁽¹⁾	D	$480	96,951.43	D
Ordinary Shares (Trust)								24,500⁽²⁾	I	By Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$78.97	10/06/2026		M			48,091	⁽³⁾	02/04/2029	Ordinary Shares	48,091	$0	0	D

Explanation of Responses:

1. Transaction executed pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 4, 2026.

2. Shares held by a revocable trust established by the reporting person's spouse, of which trust the reporting person's spouse is the sole trustee and sole beneficiary.

3. The stock option vested in three (3) pro rata annual installments beginning on February 5, 2020.

Remarks:

	/s/ Eric R. Waller, Attorney-in-Fact	10/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR